Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men

We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed typ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2013-10, Vol.62 (10), p.3618-3626
Hauptverfasser: MAHENDRAN, Yuvaraj, VANGIPURAPU, Jagadish, PAJUKANTA, Päivi, LUSIS, Aldons J, BONNYCASTLE, Lori L, MORKEN, Mario A, COLLINS, Francis S, MOHLKE, Karen L, BOEHNKE, Michael, ALA-KORPELA, Mika, KUUSISTO, Johanna, LAAKSO, Markku, CEDERBERG, Henna, STANCAKOVA, Alena, PIHLAJAMÄKI, Jussi, SOININEN, Pasi, KANGAS, Antti J, PAANANEN, Jussi, CIVELEK, Mete, SALEEM, Niyas K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3626
container_issue 10
container_start_page 3618
container_title Diabetes (New York, N.Y.)
container_volume 62
creator MAHENDRAN, Yuvaraj
VANGIPURAPU, Jagadish
PAJUKANTA, Päivi
LUSIS, Aldons J
BONNYCASTLE, Lori L
MORKEN, Mario A
COLLINS, Francis S
MOHLKE, Karen L
BOEHNKE, Michael
ALA-KORPELA, Mika
KUUSISTO, Johanna
LAAKSO, Markku
CEDERBERG, Henna
STANCAKOVA, Alena
PIHLAJAMÄKI, Jussi
SOININEN, Pasi
KANGAS, Antti J
PAANANEN, Jussi
CIVELEK, Mete
SALEEM, Niyas K
description We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed type 2 diabetes. Increasing fasting and 2-h plasma glucose levels were associated with elevated levels of acetoacetate (AcAc) and β-hydroxybutyrate (BHB). AcAc and BHB predicted an increase in the glucose area under the curve in an oral glucose tolerance test, and AcAc predicted the conversion to type 2 diabetes in a 5-year follow-up of the METSIM cohort. Impaired insulin secretion, but not insulin resistance, explained these findings. Of the 62 single nucleotide polymorphisms associated with the risk of type 2 diabetes or hyperglycemia, the glucose-increasing C allele of GCKR significantly associated with elevated levels of fasting BHB levels. Adipose tissue mRNA expression levels of genes involved in ketolysis were significantly associated with insulin sensitivity (Matsuda index). In conclusion, high levels of KBs predicted subsequent worsening of hyperglycemia, and a common variant of GCKR was significantly associated with BHB levels.
doi_str_mv 10.2337/db12-1363
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3781437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A344826581</galeid><sourcerecordid>A344826581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-445281d7948c4ef161fca698a0e55812c8841c698bca42bf8ea69de3a7c102b53</originalsourceid><addsrcrecordid>eNp9kl9rFDEUxYModm198AtIQPogOG3-zSTzImxX24orfanoi4RM5mY2ZTZZJ7PF_fZmcW1dWOQ-BO795eRychB6RckZ41yetw1lBeUVf4ImtOZ1wZn8_hRNCNn2ZS2P0IuU7gghVa7n6IjxspSSyAn6MU0pWm9GHwOODn-GMQbAF7Hd4DncQ5_wNz8u8PVmBUPXbywsvcEmtPg2dzDDH7xpYISEfcD1O14rfOlD8GmBv0A4Qc-c6RO83J3H6Ovlx9vZdTG_ufo0m84LW1EyFkKUTNFW1kJZAY5W1FlT1coQKEtFmVVKUJsbjTWCNU5BnrbAjbSUsKbkx-j9H93VullCayGMg-n1avBLM2x0NF7vT4Jf6C7eay4VFVxmgTc7gSH-XEMa9V1cDyHvrGnFFKGyLMUj1ZketA8uZjG79MnqKRdCsSpvm6niANVBgPxyNtf53N7jzw7wudrstT144e3ehcyM8GvszDolra7m_1tmx9rY99CBzr8wuzmobYeY0gDuwURK9DZsehs2vQ1bZl__6_oD-TddGTjdASZZ07vBBOvTIyelElJU_DdlBNaf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1628017554</pqid></control><display><type>article</type><title>Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Journals@Ovid Complete</source><creator>MAHENDRAN, Yuvaraj ; VANGIPURAPU, Jagadish ; PAJUKANTA, Päivi ; LUSIS, Aldons J ; BONNYCASTLE, Lori L ; MORKEN, Mario A ; COLLINS, Francis S ; MOHLKE, Karen L ; BOEHNKE, Michael ; ALA-KORPELA, Mika ; KUUSISTO, Johanna ; LAAKSO, Markku ; CEDERBERG, Henna ; STANCAKOVA, Alena ; PIHLAJAMÄKI, Jussi ; SOININEN, Pasi ; KANGAS, Antti J ; PAANANEN, Jussi ; CIVELEK, Mete ; SALEEM, Niyas K</creator><creatorcontrib>MAHENDRAN, Yuvaraj ; VANGIPURAPU, Jagadish ; PAJUKANTA, Päivi ; LUSIS, Aldons J ; BONNYCASTLE, Lori L ; MORKEN, Mario A ; COLLINS, Francis S ; MOHLKE, Karen L ; BOEHNKE, Michael ; ALA-KORPELA, Mika ; KUUSISTO, Johanna ; LAAKSO, Markku ; CEDERBERG, Henna ; STANCAKOVA, Alena ; PIHLAJAMÄKI, Jussi ; SOININEN, Pasi ; KANGAS, Antti J ; PAANANEN, Jussi ; CIVELEK, Mete ; SALEEM, Niyas K</creatorcontrib><description>We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed type 2 diabetes. Increasing fasting and 2-h plasma glucose levels were associated with elevated levels of acetoacetate (AcAc) and β-hydroxybutyrate (BHB). AcAc and BHB predicted an increase in the glucose area under the curve in an oral glucose tolerance test, and AcAc predicted the conversion to type 2 diabetes in a 5-year follow-up of the METSIM cohort. Impaired insulin secretion, but not insulin resistance, explained these findings. Of the 62 single nucleotide polymorphisms associated with the risk of type 2 diabetes or hyperglycemia, the glucose-increasing C allele of GCKR significantly associated with elevated levels of fasting BHB levels. Adipose tissue mRNA expression levels of genes involved in ketolysis were significantly associated with insulin sensitivity (Matsuda index). In conclusion, high levels of KBs predicted subsequent worsening of hyperglycemia, and a common variant of GCKR was significantly associated with BHB levels.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db12-1363</identifier><identifier>PMID: 23557707</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>3-Hydroxybutyric Acid - blood ; Acetoacetates - blood ; Area Under Curve ; Biological and medical sciences ; Biomarkers - blood ; Blood Glucose - metabolism ; Care and treatment ; Diabetes ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - genetics ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; European Continental Ancestry Group - genetics ; Fasting ; Finland - epidemiology ; Genetics ; Genome-Wide Association Study ; Glucose metabolism ; Glucose Tolerance Test ; Glucose tolerance tests ; Health aspects ; Humans ; Hyperglycemia ; Hyperglycemia - blood ; Hyperglycemia - epidemiology ; Hyperglycemia - genetics ; Insulin ; Ketone Bodies - blood ; Ketones ; Male ; Medical sciences ; Men ; Metabolic Syndrome - blood ; Metabolic Syndrome - epidemiology ; Middle Aged ; Organic chemicals ; Original Research ; Physiological aspects ; Polymorphism, Single Nucleotide ; Predictive Value of Tests ; Risk Factors ; Type 2 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2013-10, Vol.62 (10), p.3618-3626</ispartof><rights>2014 INIST-CNRS</rights><rights>COPYRIGHT 2013 American Diabetes Association</rights><rights>COPYRIGHT 2013 American Diabetes Association</rights><rights>Copyright American Diabetes Association Oct 2013</rights><rights>2013 by the American Diabetes Association. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-445281d7948c4ef161fca698a0e55812c8841c698bca42bf8ea69de3a7c102b53</citedby><cites>FETCH-LOGICAL-c610t-445281d7948c4ef161fca698a0e55812c8841c698bca42bf8ea69de3a7c102b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781437/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781437/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27784746$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23557707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MAHENDRAN, Yuvaraj</creatorcontrib><creatorcontrib>VANGIPURAPU, Jagadish</creatorcontrib><creatorcontrib>PAJUKANTA, Päivi</creatorcontrib><creatorcontrib>LUSIS, Aldons J</creatorcontrib><creatorcontrib>BONNYCASTLE, Lori L</creatorcontrib><creatorcontrib>MORKEN, Mario A</creatorcontrib><creatorcontrib>COLLINS, Francis S</creatorcontrib><creatorcontrib>MOHLKE, Karen L</creatorcontrib><creatorcontrib>BOEHNKE, Michael</creatorcontrib><creatorcontrib>ALA-KORPELA, Mika</creatorcontrib><creatorcontrib>KUUSISTO, Johanna</creatorcontrib><creatorcontrib>LAAKSO, Markku</creatorcontrib><creatorcontrib>CEDERBERG, Henna</creatorcontrib><creatorcontrib>STANCAKOVA, Alena</creatorcontrib><creatorcontrib>PIHLAJAMÄKI, Jussi</creatorcontrib><creatorcontrib>SOININEN, Pasi</creatorcontrib><creatorcontrib>KANGAS, Antti J</creatorcontrib><creatorcontrib>PAANANEN, Jussi</creatorcontrib><creatorcontrib>CIVELEK, Mete</creatorcontrib><creatorcontrib>SALEEM, Niyas K</creatorcontrib><title>Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed type 2 diabetes. Increasing fasting and 2-h plasma glucose levels were associated with elevated levels of acetoacetate (AcAc) and β-hydroxybutyrate (BHB). AcAc and BHB predicted an increase in the glucose area under the curve in an oral glucose tolerance test, and AcAc predicted the conversion to type 2 diabetes in a 5-year follow-up of the METSIM cohort. Impaired insulin secretion, but not insulin resistance, explained these findings. Of the 62 single nucleotide polymorphisms associated with the risk of type 2 diabetes or hyperglycemia, the glucose-increasing C allele of GCKR significantly associated with elevated levels of fasting BHB levels. Adipose tissue mRNA expression levels of genes involved in ketolysis were significantly associated with insulin sensitivity (Matsuda index). In conclusion, high levels of KBs predicted subsequent worsening of hyperglycemia, and a common variant of GCKR was significantly associated with BHB levels.</description><subject>3-Hydroxybutyric Acid - blood</subject><subject>Acetoacetates - blood</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Care and treatment</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - genetics</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>European Continental Ancestry Group - genetics</subject><subject>Fasting</subject><subject>Finland - epidemiology</subject><subject>Genetics</subject><subject>Genome-Wide Association Study</subject><subject>Glucose metabolism</subject><subject>Glucose Tolerance Test</subject><subject>Glucose tolerance tests</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Hyperglycemia - blood</subject><subject>Hyperglycemia - epidemiology</subject><subject>Hyperglycemia - genetics</subject><subject>Insulin</subject><subject>Ketone Bodies - blood</subject><subject>Ketones</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Men</subject><subject>Metabolic Syndrome - blood</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Middle Aged</subject><subject>Organic chemicals</subject><subject>Original Research</subject><subject>Physiological aspects</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><subject>Type 2 diabetes</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kl9rFDEUxYModm198AtIQPogOG3-zSTzImxX24orfanoi4RM5mY2ZTZZJ7PF_fZmcW1dWOQ-BO795eRychB6RckZ41yetw1lBeUVf4ImtOZ1wZn8_hRNCNn2ZS2P0IuU7gghVa7n6IjxspSSyAn6MU0pWm9GHwOODn-GMQbAF7Hd4DncQ5_wNz8u8PVmBUPXbywsvcEmtPg2dzDDH7xpYISEfcD1O14rfOlD8GmBv0A4Qc-c6RO83J3H6Ovlx9vZdTG_ufo0m84LW1EyFkKUTNFW1kJZAY5W1FlT1coQKEtFmVVKUJsbjTWCNU5BnrbAjbSUsKbkx-j9H93VullCayGMg-n1avBLM2x0NF7vT4Jf6C7eay4VFVxmgTc7gSH-XEMa9V1cDyHvrGnFFKGyLMUj1ZketA8uZjG79MnqKRdCsSpvm6niANVBgPxyNtf53N7jzw7wudrstT144e3ehcyM8GvszDolra7m_1tmx9rY99CBzr8wuzmobYeY0gDuwURK9DZsehs2vQ1bZl__6_oD-TddGTjdASZZ07vBBOvTIyelElJU_DdlBNaf</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>MAHENDRAN, Yuvaraj</creator><creator>VANGIPURAPU, Jagadish</creator><creator>PAJUKANTA, Päivi</creator><creator>LUSIS, Aldons J</creator><creator>BONNYCASTLE, Lori L</creator><creator>MORKEN, Mario A</creator><creator>COLLINS, Francis S</creator><creator>MOHLKE, Karen L</creator><creator>BOEHNKE, Michael</creator><creator>ALA-KORPELA, Mika</creator><creator>KUUSISTO, Johanna</creator><creator>LAAKSO, Markku</creator><creator>CEDERBERG, Henna</creator><creator>STANCAKOVA, Alena</creator><creator>PIHLAJAMÄKI, Jussi</creator><creator>SOININEN, Pasi</creator><creator>KANGAS, Antti J</creator><creator>PAANANEN, Jussi</creator><creator>CIVELEK, Mete</creator><creator>SALEEM, Niyas K</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>20131001</creationdate><title>Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men</title><author>MAHENDRAN, Yuvaraj ; VANGIPURAPU, Jagadish ; PAJUKANTA, Päivi ; LUSIS, Aldons J ; BONNYCASTLE, Lori L ; MORKEN, Mario A ; COLLINS, Francis S ; MOHLKE, Karen L ; BOEHNKE, Michael ; ALA-KORPELA, Mika ; KUUSISTO, Johanna ; LAAKSO, Markku ; CEDERBERG, Henna ; STANCAKOVA, Alena ; PIHLAJAMÄKI, Jussi ; SOININEN, Pasi ; KANGAS, Antti J ; PAANANEN, Jussi ; CIVELEK, Mete ; SALEEM, Niyas K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-445281d7948c4ef161fca698a0e55812c8841c698bca42bf8ea69de3a7c102b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>3-Hydroxybutyric Acid - blood</topic><topic>Acetoacetates - blood</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Care and treatment</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - genetics</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>European Continental Ancestry Group - genetics</topic><topic>Fasting</topic><topic>Finland - epidemiology</topic><topic>Genetics</topic><topic>Genome-Wide Association Study</topic><topic>Glucose metabolism</topic><topic>Glucose Tolerance Test</topic><topic>Glucose tolerance tests</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Hyperglycemia - blood</topic><topic>Hyperglycemia - epidemiology</topic><topic>Hyperglycemia - genetics</topic><topic>Insulin</topic><topic>Ketone Bodies - blood</topic><topic>Ketones</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Men</topic><topic>Metabolic Syndrome - blood</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Middle Aged</topic><topic>Organic chemicals</topic><topic>Original Research</topic><topic>Physiological aspects</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MAHENDRAN, Yuvaraj</creatorcontrib><creatorcontrib>VANGIPURAPU, Jagadish</creatorcontrib><creatorcontrib>PAJUKANTA, Päivi</creatorcontrib><creatorcontrib>LUSIS, Aldons J</creatorcontrib><creatorcontrib>BONNYCASTLE, Lori L</creatorcontrib><creatorcontrib>MORKEN, Mario A</creatorcontrib><creatorcontrib>COLLINS, Francis S</creatorcontrib><creatorcontrib>MOHLKE, Karen L</creatorcontrib><creatorcontrib>BOEHNKE, Michael</creatorcontrib><creatorcontrib>ALA-KORPELA, Mika</creatorcontrib><creatorcontrib>KUUSISTO, Johanna</creatorcontrib><creatorcontrib>LAAKSO, Markku</creatorcontrib><creatorcontrib>CEDERBERG, Henna</creatorcontrib><creatorcontrib>STANCAKOVA, Alena</creatorcontrib><creatorcontrib>PIHLAJAMÄKI, Jussi</creatorcontrib><creatorcontrib>SOININEN, Pasi</creatorcontrib><creatorcontrib>KANGAS, Antti J</creatorcontrib><creatorcontrib>PAANANEN, Jussi</creatorcontrib><creatorcontrib>CIVELEK, Mete</creatorcontrib><creatorcontrib>SALEEM, Niyas K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MAHENDRAN, Yuvaraj</au><au>VANGIPURAPU, Jagadish</au><au>PAJUKANTA, Päivi</au><au>LUSIS, Aldons J</au><au>BONNYCASTLE, Lori L</au><au>MORKEN, Mario A</au><au>COLLINS, Francis S</au><au>MOHLKE, Karen L</au><au>BOEHNKE, Michael</au><au>ALA-KORPELA, Mika</au><au>KUUSISTO, Johanna</au><au>LAAKSO, Markku</au><au>CEDERBERG, Henna</au><au>STANCAKOVA, Alena</au><au>PIHLAJAMÄKI, Jussi</au><au>SOININEN, Pasi</au><au>KANGAS, Antti J</au><au>PAANANEN, Jussi</au><au>CIVELEK, Mete</au><au>SALEEM, Niyas K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>62</volume><issue>10</issue><spage>3618</spage><epage>3626</epage><pages>3618-3626</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>We investigated the association of the levels of ketone bodies (KBs) with hyperglycemia and with 62 genetic risk variants regulating glucose levels or type 2 diabetes in the population-based Metabolic Syndrome in Men (METSIM) study, including 9,398 Finnish men without diabetes or newly diagnosed type 2 diabetes. Increasing fasting and 2-h plasma glucose levels were associated with elevated levels of acetoacetate (AcAc) and β-hydroxybutyrate (BHB). AcAc and BHB predicted an increase in the glucose area under the curve in an oral glucose tolerance test, and AcAc predicted the conversion to type 2 diabetes in a 5-year follow-up of the METSIM cohort. Impaired insulin secretion, but not insulin resistance, explained these findings. Of the 62 single nucleotide polymorphisms associated with the risk of type 2 diabetes or hyperglycemia, the glucose-increasing C allele of GCKR significantly associated with elevated levels of fasting BHB levels. Adipose tissue mRNA expression levels of genes involved in ketolysis were significantly associated with insulin sensitivity (Matsuda index). In conclusion, high levels of KBs predicted subsequent worsening of hyperglycemia, and a common variant of GCKR was significantly associated with BHB levels.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>23557707</pmid><doi>10.2337/db12-1363</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2013-10, Vol.62 (10), p.3618-3626
issn 0012-1797
1939-327X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3781437
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Journals@Ovid Complete
subjects 3-Hydroxybutyric Acid - blood
Acetoacetates - blood
Area Under Curve
Biological and medical sciences
Biomarkers - blood
Blood Glucose - metabolism
Care and treatment
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - genetics
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
European Continental Ancestry Group - genetics
Fasting
Finland - epidemiology
Genetics
Genome-Wide Association Study
Glucose metabolism
Glucose Tolerance Test
Glucose tolerance tests
Health aspects
Humans
Hyperglycemia
Hyperglycemia - blood
Hyperglycemia - epidemiology
Hyperglycemia - genetics
Insulin
Ketone Bodies - blood
Ketones
Male
Medical sciences
Men
Metabolic Syndrome - blood
Metabolic Syndrome - epidemiology
Middle Aged
Organic chemicals
Original Research
Physiological aspects
Polymorphism, Single Nucleotide
Predictive Value of Tests
Risk Factors
Type 2 diabetes
title Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T21%3A16%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Ketone%20Body%20Levels%20With%20Hyperglycemia%20and%20Type%202%20Diabetes%20in%209,398%20Finnish%20Men&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=MAHENDRAN,%20Yuvaraj&rft.date=2013-10-01&rft.volume=62&rft.issue=10&rft.spage=3618&rft.epage=3626&rft.pages=3618-3626&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db12-1363&rft_dat=%3Cgale_pubme%3EA344826581%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1628017554&rft_id=info:pmid/23557707&rft_galeid=A344826581&rfr_iscdi=true